询 单
请 填 写 相 关 信 息
产品信息
产品名称
别名
CAS号
结构式 上传
联系方式
公司
联系人
电话
邮箱
内容
提交
中文版 English
请输入产品名称、CAS式、分子式
Lepidine | CAS:491-35-0
Lepidine
  • 名称:4-甲基喹啉 | Lepidine
  • CAS号:491-35-0
  • 别名:4-Methylquinoline
  • 分子式:C10H9N
  • 分子量:143.19
  • EINESC号:207-734-2

产品描述

物理化学性质

熔点 9-10 ºC
水溶性 微溶
沸点 261-263 ºC
密度 1.083
折射率 1.618-1.62

安全数据

危险品标志 Xn
危险类别码 R36/37/38;R68
安全说明书 S26;S36/37/39;S45

SDS

来源 SDS样本
没有数据没有数据
产品合成路线
更多

名称 CAS号
更多
文章
同行评议文献
Effects of L-glutamate, substance P and substance P(1-7) on cardiovascular regulation in the nucleus tractus solitarius.M E Hall et al.Regulatory peptides, 46(1-2), 102-109 (1993-07-02) Inhibition of ERK phosphorylation by substance P N-terminal fragment decreases capsaicin-induced nociceptive response.Takaaki Komatsu et al.Neuropharmacology, 61(4), 608-613 (2011-05-24) Injection of substance P (SP) N-terminal fragment SP(1-7) into the ventral tegmental area modulates the levels of nucleus accumbens dopamine and dihydroxyphenylacetic acid in male rats during morphine withdrawal.Qin Zhou et al.Neuroscience letters, 320(3), 117-120 (2002-02-20) Endomorphin-1 and endomorphin-2 differentially interact with specific binding sites for substance P (SP) aminoterminal SP1-7 in the rat spinal cord.Milad Botros et al.Peptides, 27(4), 753-759 (2005-10-12) The substance P (SP) heptapeptide fragment SP1-7 alters the density of dopamine receptors in rat brain mesocorticolimbic structures during morphine withdrawal.Qin Zhou et al.Peptides, 25(11), 1951-1957 (2004-10-27) The C-terminal amidated analogue of the substance P (SP) fragment SP(1-7) attenuates the expression of naloxone-precipitated withdrawal in morphine dependent rats.Qin Zhou et al.Peptides, 30(12), 2418-2422 (2009-08-19) Substance P(1-7) induces antihyperalgesia in diabetic mice through a mechanism involving the naloxone-sensitive sigma receptors.Anna Carlsson et al.European journal of pharmacology, 626(2-3), 250-255 (2009-10-20) Substance P N-terminal fragment SP(1-7) attenuates chronic morphine tolerance and affects dynorphin B and nociceptin in rats.Qin Zhou et al.Peptides, 32(8), 1661-1665 (2011-07-19)
备注

Products protected by valid patents are not offered for sale in countries where the sale of such products constitutes a patent infringement and its liability is at buyer's risk.

Products currently covered by valid US Patents are offered for R&D use in accordance with 35 USC 271 +A13(1).

名称 CAS号

相关产品

相关资讯

热门标签
询 单
请 填 写 相 关 信 息
产品信息
产品名称
别名
CAS号
结构式 上传
联系方式
公司
联系人
电话
邮箱
内容
提交